Related references
Note: Only part of the references are listed.Automated Multiplex LC-MS/MS Assay for Quantifying Serum Apolipoproteins A-I, B, C-I, C-II, C-III, and E with Qualitative Apolipoprotein E Phenotyping
Irene van den Broek et al.
CLINICAL CHEMISTRY (2016)
Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease New Insights From Epidemiology, Genetics, and Biology
Borge G. Nordestgaard
CIRCULATION RESEARCH (2016)
Novel therapies for severe dyslipidemia originating from human genetics
Daniel Gaudet
CURRENT OPINION IN LIPIDOLOGY (2016)
Disialylated apolipoprotein C-III proteoform is associated with improved lipids in prediabetes and type 2 diabetes
Juraj Koska et al.
JOURNAL OF LIPID RESEARCH (2016)
Association between Apolipoprotein C-III Gene Polymorphisms and Coronary Heart Disease: A Meta-analysis
Jing-Zhan Zhang et al.
AGING AND DISEASE (2016)
Kinetic and Related Determinants of Plasma Triglyceride Concentration in Abdominal Obesity Multicenter Tracer Kinetic Study
Jan Boren et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2015)
Plasma Apolipoprotein C-III Levels, Triglycerides, and Coronary Artery Calcification in Type 2 Diabetics
Arman Qamar et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2015)
Hypertriglyceridemia Associated With Abdominal Obesity Getting Contributing Factors Into Perspective
Andre C. Carpentier
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2015)
New insights into the pathophysiology of dyslipidemia in type 2 diabetes
Marja-Riitta Taskinen et al.
ATHEROSCLEROSIS (2015)
The crucial roles of apolipoproteins E and C-III in apoB lipoprotein metabolism in normolipidemia and hypertriglyceridemia
Frank M. Sacks
CURRENT OPINION IN LIPIDOLOGY (2015)
Protein biomarkers for the prediction of cardiovascular disease in type 2 diabetes
Helen C. Looker et al.
DIABETOLOGIA (2015)
APOA5-1131T>C and APOC3-455T>C polymorphisms are associated with an increased risk of coronary heart disease
Y. Sun et al.
GENETICS AND MOLECULAR RESEARCH (2015)
The risk of cardiovascular events with increased apolipoprotein CIII: A systematic review and meta-analysis
Moritz C. Wyler von Ballmoos et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2015)
Association of APOC3 Loss-of-Function Mutations With Plasma Lipids and Subclinical Atherosclerosis The Multi-Ethnic BioImage Study
Pradeep Natarajan et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Development of multiplex mass spectrometric immunoassay for detection and quantification of apolipoproteins C-I, C-II, C-III and their proteoforms
Olgica Trenchevska et al.
METHODS (2015)
Antisense Inhibition of Apolipoprotein C-III in Patients with Hypertriglyceridemia
Daniel Gaudet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Apolipoprotein C-III: From Pathophysiology to Pharmacology
Giuseppe Danilo Norata et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
The Association of Human Apolipoprotein C-III Sialylation Proteoforms with Plasma Triglycerides
Hussein N. Yassine et al.
PLOS ONE (2015)
Gene Therapy for Hypercholesterolemia Sweet Dreams and Flying Machines
Murray W. Huff et al.
CIRCULATION RESEARCH (2014)
Postprandial hypertriglyceridemia as a coronary risk factor
Jan Boren et al.
CLINICA CHIMICA ACTA (2014)
Inhibition of ApoCIII: the next PCSK9?
Sophie J. Bernelot Moens et al.
CURRENT OPINION IN LIPIDOLOGY (2014)
Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease
Anders Berg Jorgensen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Targeting APOC3 in the Familial Chylomicronemia Syndrome
Daniel Gaudet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Loss-of-Function Mutations in APOC3, Triglycerides, and Coronary Disease
Jacy Crosby et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
A rare variant in APOC3 is associated with plasma triglyceride and VLDL levels in Europeans
Nicholas J. Timpson et al.
NATURE COMMUNICATIONS (2014)
Apolipoprotein C-III Going Back to the Future for a Lipid Drug Target
Murray W. Huff et al.
CIRCULATION RESEARCH (2013)
Antisense Oligonucleotide Inhibition of Apolipoprotein C-III Reduces Plasma Triglycerides in Rodents, Nonhuman Primates, and Humans
Mark J. Graham et al.
CIRCULATION RESEARCH (2013)
Potential of Proprotein Convertase Subtilisin/Kexin Type 9 Based Therapeutics
Evan A. Stein et al.
CURRENT ATHEROSCLEROSIS REPORTS (2013)
Ectopic lipid storage and insulin resistance: a harmful relationship
J. Boren et al.
JOURNAL OF INTERNAL MEDICINE (2013)
A rare functional cardioprotective APOC3 variant has risen in frequency in distinct population isolates
Ioanna Tachmazidou et al.
NATURE COMMUNICATIONS (2013)
Apolipoprotein C-III and hepatic triglyceride-rich lipoprotein production
Zemin Yao et al.
CURRENT OPINION IN LIPIDOLOGY (2012)
Apolipoprotein C-III as a Potential Modulator of the Association Between HDL-Cholesterol and Incident Coronary Heart Disease
Majken K. Jensen et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2012)
Dual Metabolic Defects Are Required to Produce Hypertriglyceridemia in Obese Subjects
Marja-Riitta Taskinen et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Transcriptional Activation of Apolipoprotein CIII Expression by Glucose May Contribute to Diabetic Dyslipidemia
Sandrine Caron et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Low-Density Lipoproteins Containing Apolipoprotein C-III and the Risk of Coronary Heart Disease
Carlos O. Mendivil et al.
CIRCULATION (2011)
Development of a sensitive ELISA to quantify apolipoprotein CIII in nonhuman primate serum
Yuxin Wang et al.
JOURNAL OF LIPID RESEARCH (2011)
Apolipoprotein C-III and the Metabolic Basis for Hypertriglyceridemia and the Dense Low-Density Lipoprotein Phenotype
Chunyu Zheng et al.
CIRCULATION (2010)
Effect of increasing doses of Rosuvastatin and Atorvastatin on apolipoproteins, enzymes and lipid transfer proteins involved in lipoprotein metabolism and inflammatory parameters
Ioannis K. Karalis et al.
CURRENT MEDICAL RESEARCH AND OPINION (2010)
ApoCIII-Enriched LDL in Type 2 Diabetes Displays Altered Lipid Composition, Increased Susceptibility for Sphingomyelinase, and Increased Binding to Biglycan
Anne Hiukka et al.
DIABETES (2009)
Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome
Martin Adiels et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Apolipoprotein CIII and atherosclerosis - Beyond effects on lipid metabolism
Alex Bobik
CIRCULATION (2008)
Toll-Like Receptor 2 Mediates Apolipoprotein CIII-Induced Monocyte Activation
Akio Kawakami et al.
CIRCULATION RESEARCH (2008)
Increased plasma apolipoprotein C-III concentration independently predicts cardiovascular mortality: The Hoorn Study
Peter G. Scheffer et al.
CLINICAL CHEMISTRY (2008)
Apolipoprotein C-III: understanding an emerging cardiovascular risk factor
Esther M. M. Ooi et al.
CLINICAL SCIENCE (2008)
Structure and dynamics of human apolipoprotein CIII
Chinthaka Saneth Gangabadage et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
A Null Mutation in Human APOC3 Confers a Favorable Plasma Lipid Profile and Apparent Cardioprotection
Toni I. Pollin et al.
SCIENCE (2008)
The liver X receptor (LXR) and hepatic lipogenesis - The carbohydrate-response element-binding protein is a target gene of LXR
Ji-Young Cha et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Apolipoprotein CIII-induced THP-1 cell adhesion to endothelial cells involves pertussis toxin-sensitive G protein- and protein kinase C alpha-mediated nuclear factor-kappa B activation
Akio Kawakami et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Hepatocyte nuclear factor-4α contributes to carbohydrate-induced transcriptional activation of hepatic fatty acid synthase
Aaron W. Adamson et al.
BIOCHEMICAL JOURNAL (2006)
Apolipoprotein CIII induces expression of vascular cell adhesion molecule-1 in vascular endothelial cells and increases adhesion of monocytic cells
Akio Kawakami et al.
CIRCULATION (2006)
Role of apoA-I, ABCA1, LCAT, and SR-BI in the biogenesis of HDL
Vassilis I. Zannis et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2006)
Glucose as a regulator of eukaryotic gene transcription
HC Towle
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2005)
A proteomic study of the apolipoproteins in LDL subclasses in patients with the metabolic syndrome and type 2 diabetes
P Davidsson et al.
JOURNAL OF LIPID RESEARCH (2005)
Alterations of lipids and apolipoprotein CIII in very low density lipoprotein subspecies in type 2 diabetes
A Hiukka et al.
DIABETOLOGIA (2005)
Mechanism of lipoprotein retention extracellular matrix
M Gustafsson et al.
CURRENT OPINION IN LIPIDOLOGY (2004)
Retention of atherogenic lipoproteins in atherogenesis
M Gustafsson et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2004)
Atorvastatin decreases apolipoprotein C-III in apolipoprotein B-containg lipoprotein and HDL in type 2 diabetes - A potential mechanism to lower plasma triglycerides
GM Dallinga-Thie et al.
DIABETES CARE (2004)
Deficiency of carbohydrate response element-binding protein (ChREBP) reduces lipogenesis as well as glycolysis
K Iizuka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Mutations in PCSK9 cause autosomal dominant hypercholesterolemia
M Abifadel et al.
NATURE GENETICS (2003)
LDL containing apolipoprotein CIII is an independent risk factor for coronary events in diabetic patients
SJ Lee et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
ApoC-III content of apoB-containing lipoproteins is associated with binding to the vascular proteoglycan biglycan
K Olin-Lewis et al.
JOURNAL OF LIPID RESEARCH (2002)
Lipid-interacting properties of the N-terminal domain of human apolipoprotein C-III
L Lins et al.
PROTEIN ENGINEERING (2002)
A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver
H Yamashita et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Transcriptional regulatory mechanisms of the human apolipoprotein genes in vitro and in vivo
VI Zannis et al.
CURRENT OPINION IN LIPIDOLOGY (2001)
VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial
FM Sacks et al.
CIRCULATION (2000)
Role of extracellular retention of low density lipoproteins in atherosclerosis
J Borén et al.
CURRENT OPINION IN LIPIDOLOGY (2000)
Characterization of recombinant wild type and site-directed mutations of apolipoprotein C-III: Lipid binding, displacement of ApoE, and inhibition of lipoprotein lipase
HQ Liu et al.
BIOCHEMISTRY (2000)
Hydrolysis of phospholipids by purified milk lipoprotein lipase - Effect of apoprotein CII, CIII, A and E, and synthetic fragments
DA Lambert et al.
CLINICA CHIMICA ACTA (2000)
Molecular basis of exchangeable apolipoprotein function
V Narayanaswami et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2000)
Share Paper
